1. Home
  2. ELOG vs CMMB Comparison

ELOG vs CMMB Comparison

Compare ELOG & CMMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eastern International Ltd. Ordinary Shares

ELOG

Eastern International Ltd. Ordinary Shares

N/A

Current Price

$0.85

Market Cap

11.1M

Sector

Industrials

ML Signal

N/A

Logo Chemomab Therapeutics Ltd.

CMMB

Chemomab Therapeutics Ltd.

HOLD

Current Price

$1.59

Market Cap

10.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELOG
CMMB
Founded
2006
2004
Country
China
Israel
Employees
N/A
N/A
Industry
Integrated Freight & Logistics
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.1M
10.8M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
ELOG
CMMB
Price
$0.85
$1.59
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$25.00
AVG Volume (30 Days)
13.5K
217.7K
Earning Date
07-17-2026
05-21-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
101.67
EPS
N/A
0.04
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$6.84
$38.13
Revenue Growth
N/A
N/A
52 Week Low
$0.80
$0.87
52 Week High
$3.07
$3.86

Technical Indicators

Market Signals
Indicator
ELOG
CMMB
Relative Strength Index (RSI) 41.32 42.90
Support Level N/A $1.51
Resistance Level $0.97 $1.83
Average True Range (ATR) 0.06 0.27
MACD -0.00 -0.05
Stochastic Oscillator 0.00 2.24

Price Performance

Historical Comparison
ELOG
CMMB

About ELOG Eastern International Ltd. Ordinary Shares

Eastern International Ltd is a holding company. The company operates through its subsidiary engaged in domestic and cross-border professional logistic services including project logistics and general logistics for company clients. Its project logistic services include Construction project logistics and special cargo logistics for large or precision equipment and General logistic services refer to the transportation, warehousing, loading and unloading, and distribution of ordinary products.

About CMMB Chemomab Therapeutics Ltd.

Chemomab Therapeutics Ltd is a clinical-stage biotechnology company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases.

Share on Social Networks: